Combating Illicit Xylazine Act
Sponsored By: Representative Panetta
Introduced
Summary
This bill would place xylazine on Schedule III of the Controlled Substances Act to curb illicit use and trafficking. It would also redefine who may possess xylazine legally, add the drug to federal tracking systems, and require sentencing guidance and periodic reports to Congress.
Show full summary
- Veterinarians and animal owners: The bill limits who counts as an "ultimate user" to people who receive xylazine from a veterinarian or a registered pharmacy. Possession is restricted to animals they own or care for and to government or wildlife program uses.
- Manufacturers and practitioners: Entities manufacturing xylazine at enactment would not have to install new capital security standards. Labeling rules are delayed for 1 year and practitioner registration, inventory, and recordkeeping requirements are delayed for 60 days to allow a transition.
- Law enforcement and courts: Federal ARCOS tracking would be expanded to include xylazine. The U.S. Sentencing Commission must review penalties and the Attorney General, DEA, and FDA must report to Congress at 18 months and again at 4 years on prevalence, trafficking, and related risks.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Transition relief for xylazine makers and vets
If enacted, xylazine businesses would get transition relief. Existing makers would not have to install new Schedule III security systems. Labeling and shipping rules would start 1 year after enactment. Practitioner registration and record rules would start 60 days after enactment, and applicants could keep working while applications are pending. FDA and DEA would speed related paperwork for manufacturers.
Stronger federal controls on xylazine
If enacted, the government would treat xylazine as a Schedule III drug. DEA would add it to its national drug reporting system. Makers, distributors, and pharmacies would have to report xylazine shipments. The Sentencing Commission would review penalties for xylazine crimes. The bill would also define xylazine to include its salts and isomers.
Who can hold xylazine for animals
If enacted, a person who gets xylazine from a registered vet or pharmacy for an animal they own or care for would be the “ultimate user.” You would not need to register to possess that xylazine. This would also cover government animal‑control and wildlife programs, and businesses where animals are kept.
Sponsors & CoSponsors
Sponsor
Panetta
CA • D
Cosponsors
Pfluger
TX • R
Sponsored 2/12/2025
Bilirakis
FL • R
Sponsored 2/12/2025
Pappas
NH • D
Sponsored 2/12/2025
Fitzgerald
WI • R
Sponsored 2/12/2025
Ross
NC • D
Sponsored 2/12/2025
Crenshaw
TX • R
Sponsored 2/12/2025
Harder (CA)
CA • D
Sponsored 2/12/2025
DelBene
WA • D
Sponsored 2/12/2025
Miller-Meeks
IA • R
Sponsored 2/12/2025
Pettersen
CO • D
Sponsored 2/12/2025
Clarke (NY)
NY • D
Sponsored 2/12/2025
Deluzio
PA • D
Sponsored 2/12/2025
Magaziner
RI • D
Sponsored 2/12/2025
Bacon
NE • R
Sponsored 2/12/2025
Obernolte
CA • R
Sponsored 2/12/2025
Costa
CA • D
Sponsored 2/12/2025
Balderson
OH • R
Sponsored 2/12/2025
Barragan
CA • D
Sponsored 2/12/2025
Ciscomani
AZ • R
Sponsored 2/12/2025
Carey
OH • R
Sponsored 2/12/2025
Bice
OK • R
Sponsored 2/12/2025
Craig
MN • D
Sponsored 2/12/2025
Norcross
NJ • D
Sponsored 2/12/2025
Fong
CA • R
Sponsored 2/12/2025
Tenney
NY • R
Sponsored 2/12/2025
Fitzpatrick
PA • R
Sponsored 2/12/2025
Burchett
TN • R
Sponsored 2/12/2025
Dean (PA)
PA • D
Sponsored 2/12/2025
Cohen
TN • D
Sponsored 2/12/2025
Davis (NC)
NC • D
Sponsored 2/12/2025
Correa
CA • D
Sponsored 2/12/2025
Webster (FL)
FL • R
Sponsored 2/12/2025
Collins
GA • R
Sponsored 2/12/2025
Suozzi
NY • D
Sponsored 2/12/2025
Harshbarger
TN • R
Sponsored 2/12/2025
Salinas
OR • D
Sponsored 2/14/2025
Lee (FL)
FL • R
Sponsored 2/14/2025
Wittman
VA • R
Sponsored 2/14/2025
Mann
KS • R
Sponsored 2/14/2025
Soto
FL • D
Sponsored 2/14/2025
Cherfilus-McCormick
FL • D
Sponsored 2/24/2025
Haridopolos
FL • R
Sponsored 2/24/2025
Sewell
AL • D
Sponsored 2/24/2025
Rulli
OH • R
Sponsored 2/24/2025
Finstad
MN • R
Sponsored 2/25/2025
Davids (KS)
KS • D
Sponsored 2/25/2025
Yakym
IN • R
Sponsored 2/25/2025
Self
TX • R
Sponsored 3/3/2025
Harris (MD)
MD • R
Sponsored 3/3/2025
Calvert
CA • R
Sponsored 3/3/2025
Johnson (SD)
SD • R
Sponsored 3/3/2025
Kelly (IL)
IL • D
Sponsored 3/5/2025
Steil
WI • R
Sponsored 3/5/2025
Vindman
VA • D
Sponsored 3/25/2025
McDowell
NC • R
Sponsored 3/31/2025
Sorensen
IL • D
Sponsored 4/24/2025
Auchincloss
MA • D
Sponsored 5/29/2025
Van Drew
NJ • R
Sponsored 6/12/2025
Knott
NC • R
Sponsored 7/14/2025
Smith (NJ)
NJ • R
Sponsored 7/17/2025
Thompson (CA)
CA • D
Sponsored 7/17/2025
Rouzer
NC • R
Sponsored 7/21/2025
Simpson
ID • R
Sponsored 7/21/2025
Rescom. Hernández, Pablo Jose [D-PR-At Large]
PR • D
Sponsored 7/21/2025
Tokuda
HI • D
Sponsored 7/23/2025
Grothman
WI • R
Sponsored 7/29/2025
Gray
CA • D
Sponsored 7/29/2025
Bentz
OR • R
Sponsored 8/1/2025
Min
CA • D
Sponsored 8/12/2025
Carter (GA)
GA • R
Sponsored 8/15/2025
Letlow
LA • R
Sponsored 8/19/2025
Baird
IN • R
Sponsored 8/19/2025
Scholten
MI • D
Sponsored 8/29/2025
Kim
CA • R
Sponsored 9/2/2025
Van Duyne
TX • R
Sponsored 9/8/2025
Weber (TX)
TX • R
Sponsored 9/9/2025
Nunn (IA)
IA • R
Sponsored 9/9/2025
McDonald Rivet
MI • D
Sponsored 9/9/2025
Nehls
TX • R
Sponsored 9/9/2025
Van Orden
WI • R
Sponsored 9/9/2025
Budzinski
IL • D
Sponsored 9/10/2025
McBride
DE • D
Sponsored 9/11/2025
Lucas
OK • R
Sponsored 9/15/2025
Jackson (TX)
TX • R
Sponsored 9/19/2025
Fischbach
MN • R
Sponsored 9/26/2025
Kennedy (NY)
NY • D
Sponsored 9/30/2025
Evans (CO)
CO • R
Sponsored 10/17/2025
Schrier
WA • D
Sponsored 10/17/2025
Schmidt
KS • R
Sponsored 10/17/2025
Lofgren
CA • D
Sponsored 12/4/2025
Riley (NY)
NY • D
Sponsored 12/9/2025
Garamendi
CA • D
Sponsored 12/17/2025
Vasquez
NM • D
Sponsored 1/6/2026
Perez
WA • D
Sponsored 1/7/2026
DesJarlais
TN • R
Sponsored 2/9/2026
Ivey
MD • D
Sponsored 2/11/2026
Bergman
MI • R
Sponsored 2/24/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govRelated Bills
HR1262 — Mikaela Naylon Give Kids a Chance Act
Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.
HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.
HR1422 — Enhanced Iran Sanctions Act of 2025
Targets Iran's energy revenue through global sanctions. This bill would create a broad sanctions framework to punish foreign persons who process, export, or sell Iran-origin oil, condensates, gas, LNG, or petrochemical products. It pairs blocking of assets and visa bans with ownership-based triggers, waivers, humanitarian carve-outs, and new reporting to limit Iran's access to energy markets and finance for weapons and terrorism. - Foreign energy firms and financial institutions would face blocking of property and bans on transactions if they knowingly handle Iran-origin energy or are 50% or more owned by such actors. Associated aliens could become inadmissible and have visas revoked. - Maritime operators, insurers, flag registries, and LNG pipeline facilities would be exposed to sanctions risk when linked to Iran-origin shipments, though safety-of-crew rules and specific exemptions for imports remain. - Humanitarian organizations would keep explicit exemptions for agricultural commodities, food, medicine, medical devices, and humanitarian assistance to avoid disrupting aid. - U.S. agencies and private companies would see new duties: an interagency working group and multilateral contact group would coordinate enforcement, and private-sector reporting would be required to flag evasion and proceeds from intercepted Iran-origin energy sales.
HR909 — Crime Victims Fund Stabilization Act of 2025
Would make the False Claims Act apply to deposits to the Crime Victims Fund through FY2029. It would also require an Inspector General audit that sets the audit's scope, timing, and recipients, and the measure is titled the Crime Victims Fund Stabilization Act of 2025. - Entities that make deposits to the Crime Victims Fund would be subject to the False Claims Act (31 U.S.C. 3729–3731) for deposits from enactment through FY2029. - An Inspector General audit would examine the Crime Victims Fund and the bill would set the audit's scope, timing, and who receives the report.
HR2102 — Major Richard Star Act
Establishes concurrent receipt for retirees with combat-related disabilities. This bill would let eligible retirees receive both military retired pay and veterans' disability compensation for the same months without the offset rules that currently reduce payments. - Families of disabled retirees: Veterans with combat-related disabilities would receive both retired pay and VA disability compensation for the same months, increasing their monthly household income. - Defense and VA payment rules: The bill would amend 10 U.S.C. 1413a and 10 U.S.C. 1414 to exempt retired pay from reductions under 38 U.S.C. 5304 and 5305 and add a clear monthly no-offset rule. - Implementation and technical changes: It renames and updates chapter sections, adjusts cross-references, and applies to payments beginning the first month after enactment.
HR979 — AM Radio for Every Vehicle Act of 2025
This bill would require AM broadcast capability to be installed as standard equipment in passenger motor vehicles. It focuses on driver-accessible AM reception, allows digital AM audio to count for compliance, and links vehicle AM capability to emergency alerting through IPAWS. - Drivers and households: Built-in, driver-accessible AM reception would make it easier for people to get local AM stations and emergency alerts from their vehicles. The bill allows devices that receive digital AM to meet the requirement. - Vehicle manufacturers: The Department of Transportation would need to issue a rule within 1 year, with a general compliance deadline no later than 2 years after the rule is issued. Small manufacturers that produced no more than 40,000 passenger vehicles in 2022 would get at least 4 years to comply. - Oversight and emergency systems: States would be barred from imposing their own AM-access rules. The bill mandates interim labels and pricing protections for cars without AM, authorizes civil penalties and DOJ injunctions for violations, requires a GAO study and a congressional briefing within 1 year, and includes an 8-year sunset for the authority.
Take It Personal
Get Your Personalized Policy View
Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.
Already have an account? Sign in